Euroasian Journal of Hepato-Gastroenterology

Register      Login

VOLUME 2 , ISSUE 1 ( January-June, 2012 ) > List of Articles

ORIGINAL ARTICLE

Prevalence of Hepatitis B and C among Hemodialysis Patients of Tripura, India

Kalyan Debnath, Pradip Bhaumik

Citation Information : Debnath K, Bhaumik P. Prevalence of Hepatitis B and C among Hemodialysis Patients of Tripura, India. Euroasian J Hepatogastroenterol 2012; 2 (1):10-13.

DOI: 10.5005/jp-journals-10018-1023

License: CC BY-NC 4.0

Published Online: 01-01-2012


Abstract

Introduction: Hemodialysis is a trusted intermediate procedure for management of chronic kidney disease (CKD) patients. As such CKD is an immune-deficient state, hence, they may be infected by hepatitis B virus (HCV) and hepatitis C virus (HCV) during hemodialysis. Eventually, HBV and HCV infection is an important cause of morbidity and mortality among patients of hemodialysis. Prevalence of HBV and HCV infection among hemodialysis patients is highly variable. Aim of the study: This study was designed to see the prevalence of HBV and HCV among hemodialysis patients of Tripura, India and to evaluate the mode of transmission. Materials and methods: This is a single center prospective study among the patients who has come for hemodialysis at the Dialysis Unit of Agartala Government Medical College and Govinda Ballav Pant Hospital during the period of January 2011 to June 2011. Results: Male predominance has been observed among the hemodialysis patients and mean age of the patients was 48.16 years. New HBV infection was found in 5.5% of the hemodialysis patients (cumulative 7.3%) and 10.9% (cumulative 12.12%) of patients got new HCV infection during hemodialysis. Coinfection with both HBV and HCV was found among 1.2% of hemodialysis patients. History of blood transfusion was found in 100% of newly infected HBV and HCV patients. Discussion: The evaluation suggests that blood transfusion may be the single most important risk factor for HBV and HCV infection among hemodialysis patients. Newer methods of screening of blood in blood bank like nucleic acid test or polymerase chain reaction amplification of nucleic acids should be adopted to prevent HBV and HCV transmission


PDF Share
  1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97-107
  2. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, Antwerp, Belgium. J Viral Hepat 1999;6:35-47
  3. Hepatitis B and C and renal failure. Infect Dis Clin North Am 2001;15:877-99
  4. Sero-response to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsis. Am J Epidemiol 1988;127:772-82
  5. A 10-year follow-up of a hepatitis B epidemic in a dialysis unit. Scand J Infect Dis 1982;14:165-69
  6. Prevalence of hepatitis B and C viral infections in Indian patients with chronic renal failure. Intervirology 2004;47:374-76
  7. Schiff’s diseases of the liver (10th ed), volume-I
  8. Hepatitis B virus infection and related factors in hemodialysis patients in China—systemic review and meta-analysis. Ren Fail 2010;32;1255-64
  9. Hepatitis B virus infection in hemodialysis centers from Santa Catarina state, Southern Brazil. Predictive risk factors for infection and molecular epidemiology. BMC Public Health 2004;4:13. Prevalence of Hepatitis B and C among Hemodialysis Patients of Tripura, India Euroasian Journal of Hepato-Gastroenterology, January-June 2012;2(1):10-13 13 EJOHG 10. Johnson DW, Dent H, Yao Q, et al. Frequencies of hepatitis B and C infection among hemodialysis and peritoneal dialysis patients in Asia-Pacific countries: Analysis of registry data. Nephrol Dial Transplant 2009;24;1598-603
  10. The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med 1990;112:958-60
  11. National surveillance of dialysis associated diseases in the United States, 2011. Semin Dial 2004;17:310-19
  12. Hepatitis C infection and related factors in hemodialysis patients in China: Systemic review and meta-analysis. Ren Fail 2009;31:610-20
  13. Lack of impact of hepatitis C virus coinfection in end-stage renal diseases patients with hepatitis B virus infection. Transplant Proc 2005;37: 2080-82
  14. Outbreaks of hepatitis B virus infection among hemodialysis patients—California, Nebraska and Texas 1994. MMWR Morb Mortal Wkly Rep 1996;45:285-89
  15. National surveillance of dialysis associated diseases in the United States 2002. Semin Dial 2005;18:52-61
  16. Hepatitis B and C in Dialysis Units in Iran: Changing the epidemiology. Hemodial Int 2008;12:378-82
  17. Prevalence of HBV and HCV dual infection in patients on hemodialysis. Indian Journal of Medical Microbiology 2005, 10/23, Issue I: 41-43
  18. New strategies for blood donor screening for hepatitis B virus: Nucleic acid testing versus immunoassay methods. Mol Diagn Ther 2006;10:77-91
  19. Impact of individual- donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion 2009;49:1115-25.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.